#USA #Veeva Systems #Pleasanton #AI Agents #Veeva AI

Veeva AI Agents Set to Transform Life Sciences Applications

Veeva Systems, a prominent player in cloud software solutions for the life sciences industry, has unveiled plans to roll out its AI Agents starting in December 2025. These agents are designed to enhance various Veeva applications, significantly impacting the commercial, R&D, and quality sectors of life sciences.

What are Veeva AI Agents?

Veeva AI Agents are advanced, industry-specific artificial intelligence tools aimed at enhancing user interaction and operational efficiency. Operating within the Veeva Vault Platform, these agents are tailored for various high-impact functions, including clinical, regulatory, safety, quality, medical, and commercial tasks. The Veeva AI Agents will leverage large language models (LLMs) from leading AI developers such as Anthropic and Amazon, hosted on the robust Amazon Bedrock.

Planned Availability and Features

The rollout of Veeva AI Agents is strategically scheduled over several months:

• - December 2025: Launch of Vault CRM and PromoMats capabilities.
• - April 2026: Introduction of Safety and Quality features.
• - August 2026: Expansion into Clinical Operations, Regulatory, and Medical fields.
• - December 2026: Final phase launch focusing on Clinical Data.

These agents are engineered with specific prompts and safeguards tailored to the Veeva applications, ensuring secure access to necessary data, documents, and workflows. This robustness allows healthcare professionals to make informed decisions quickly and efficiently.

Customization for Client Needs

One of the standout features of Veeva AI is its configurability. Customers will have the flexibility to adapt and extend these AI Agents to suit their unique needs. They can also create their own custom agents using Veeva-hosted models or client-supplied models on platforms like Amazon Bedrock or Microsoft Azure AI Foundry.

Expected Impact on Life Sciences

Peter Gassner, CEO of Veeva, emphasized the transformative power of AI in the drug development process. He stated, "AI will fundamentally change how drugs are developed and how treatment decisions are made at the point of care. Our goal with Veeva AI is to help the industry greatly increase innovation and productivity so better medicines reach more patients, faster."

With Veeva AI's usage-based pricing model, customers can implement AI solutions without significant upfront investments, allowing for scalable growth tailored to their requirements.

Conclusion

As the life sciences industry evolves, the integration of Veeva AI Agents stands to make a considerable impact not just on operations, but on the broader goal of improving patient outcomes and accelerating medicine delivery. For continual updates and information on Veeva AI, customers can visit the Veeva AI Community on Veeva Connect.

About Veeva Systems

Veeva Systems specializes in providing innovative cloud-based software, data, and consulting services for the life sciences sector. Serving over 1,500 clients, from global biopharmaceutical giants to emerging biotech firms, Veeva is dedicated to ensuring customer success and fostering ongoing innovation within the industry. As a Public Benefit Corporation, Veeva balances the needs of its stakeholders, including customers, employees, shareholders, and industry partners.

For further details, visit veeva.com.